Technetium‐99m (V) dimercaptosuccinic acid uptake by choroidal melanoma before and after iodine‐ 125 brachytherapy

Abstract

Technetium-99m (V) DMSA scintigraphy can accurately detect choroidal melanoma and document tumour response following episcleral radioactive plaque therapy. As such, this test can be an alternative ancillary investigative tool in the rare event of opaque media or diagnostic uncertainty.

Dimercaptosuccinic acid: A multifunctional cost effective agent for imaging and therapy

“…[ 51 ] Intraocular tumor of metastatic breast, lung, and rectal carcinomas can be imaged by Tc-99m (V) DMSA. The scan also detected unknown primary and other systemic lesions that may help in the diagnosis and the management of these patients[ 52 53 54 ] [ Table 2 ]. This group suggested the complementary role of Tc-99m (V) DMSA on rare situations of decision making.…”